# Hepatitis B Vaccination in HIV-infected Adults

> **NCT02713620** · PHASE4 · COMPLETED · sponsor: **Chiang Mai University** · enrollment: 154 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** recombinant HBV vaccine (Hepavax-Gene® Berna, Korea)

## Key facts

- **NCT ID:** NCT02713620
- **Lead sponsor:** Chiang Mai University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2017-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02713620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02713620, "Hepatitis B Vaccination in HIV-infected Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02713620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*